How big is the annuloplasty system market?

As of 2027 the market size of annuloplasty system is valued at USD 518.26 million.

How is the annuloplasty system industry projected to perform over the next decade?

Annuloplasty System Market size was around USD 496.8 million in 2026 and is slated to grow at a 5.13% CAGR from 2027 to 2036, surpassing USD 819.31 million by 2036.

How is rising cardiovascular disease prevalence influencing demand for annuloplasty systems?

Increasing cardiovascular disease burden is driving higher volumes of valve repair procedures, supporting adoption of annuloplasty systems that help restore native valve function and improve procedural outcomes in cardiac care pathways.

How is the aging population affecting adoption of annuloplasty-based valve repair procedures?

Growing elderly populations are increasing cases of degenerative valve disease, encouraging earlier intervention with annuloplasty systems to stabilize valve structure and maintain cardiac function in age-related mitral and tricuspid disorders.

Why does mitral valve repair dominate the annuloplasty system market?

Mitral valve repair leads with 59.66% share due to established surgical adoption, procedural familiarity, and routine integration of annuloplasty systems to restore valve geometry and repair stability.

What is driving growth in tricuspid valve repair?

Tricuspid valve repair is growing fastest as clinical focus expands toward earlier intervention and increased willingness to treat previously underprioritized valve conditions with repair-based approaches.

Why does North America dominate the annuloplasty system market?

North America held a 43.57% market share in 2026, supported by advanced cardiac care infrastructure, experienced surgeons, and routine adoption of valve repair technologies in specialized hospitals.

How is Asia Pacific expanding in the annuloplasty system market?

Asia Pacific is expected to grow at a 6.22% CAGR, driven by expanding cardiac treatment access, stronger hospital capabilities, and increasing adoption of valve repair procedures.

Who are the major participants shaping the annuloplasty system landscape?

Top players in the annuloplasty system market include Medtronic plc (Ireland), Abbott Laboratories (United States), Edwards Lifesciences Corporation (United States), Corcym S.r.l. (Italy), Valcare Medical (Israel), Labcor Laboratórios Ltda (Brazil), Braile Biomédica (Brazil), Affluent Medical (France), Micro Interventional Devices, Inc. (United States).